Mass Surgical Supply Llc Durable Medical Equipment & Medical Supplies Location: 249 High St, Holyoke, Massachusetts 01040 Phone: (413) 532-1401 |
Cvs Pharmacy #16586 Durable Medical Equipment & Medical Supplies Location: 50 Holyoke St, Holyoke, Massachusetts 01040 Phone: (413) 532-9568 |
Cvs Pharmacy #00373 Durable Medical Equipment & Medical Supplies Location: 250 Whiting Farms Rd, Holyoke, Massachusetts 01040 Phone: (413) 532-3216 |
Cvs Pharmacy # 02071 Durable Medical Equipment & Medical Supplies Location: 400 Beech St, Holyoke, Massachusetts 01040 Phone: (413) 536-1432 |
Walgreens #4967 Durable Medical Equipment & Medical Supplies Location: 1588 Northampton St, Holyoke, Massachusetts 01040 Phone: (413) 493-3901 |
Stop & Shop Pharmacy #9 Durable Medical Equipment & Medical Supplies Location: 28 Lincoln St, Holyoke, Massachusetts 01040 Phone: (413) 552-3180 |
Stop & Shop Pharmacy #30 Durable Medical Equipment & Medical Supplies Location: 2265 Northampton St, Holyoke, Massachusetts 01040 Phone: (413) 536-9101 |
Holyoke Health Center Pharmacy Community/Retail Pharmacy Location: 230 Maple Street, Holyoke, Massachusetts 01040 Phone: (413) 420-2285 |
Eye Center Of Optical Inc Medicare Supplier Location: 10 Hospital Dr, Holyoke, Massachusetts 01040 Phone: (413) 774-7016 |
Pioneer Eye Associates Pc Medicare Supplier Location: 2 Hospital Dr, Holyoke, Massachusetts 01040 Phone: (413) 536-8670 |
Lenscrafters #198 Eyewear Supplier (Equipment, not the service) Location: 50 Holyoke St, Holyoke, Massachusetts 01040 Phone: (413) 532-9279 |
News Archive
Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) of BARACLUDE for the treatment of chronic hepatitis B (CHB) in adult patients with decompensated liver disease.
In a surprising result, Michigan State University researchers looking at the effects of diet on bowel disease found that mice on a calorie-restricted diet were more likely to die after being infected with an inflammation-causing bacterial pathogen in the colon.
Virtually all patients who develop myeloma have an asymptomatic disease called monoclonal gammopathy of undetermined significance (MGUS) in the years before the onset of myeloma. The five-year relative survival rate for myeloma is 69% for patients diagnosed with stage I or localized disease, compared with 45% for patients with advanced cancer.
"The high cost of securing health insurance for all Americans, the top domestic priority of President Obama, has Congressional Democrats scrambling to scale back their proposals or find ways to trim tens of billions of dollars a year from existing health programs," the New York Times reports.
› Verified 9 days ago